The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Funding will advance commercialization of the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
First-in-human SWITCH study demonstrates long-term safety of Stentrode neuroprosthesis device in patients with severe paralysis NEW YORK--(BUSINESS WIRE)--Synchron, an implantable brain-computer ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain-computer interface company, and Team Gleason, a foundation dedicated to improving the lives of people living with Amyotrophic Lateral Sclerosis (ALS), ...
Synchron’s brain-computer interface device is being developed to allow patients with mobility challenges to operate certain technology with their mind. Synchron, a brain-computer interface (BCI) ...
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Top-tier investor syndicate includes new investors ...
Synchron, a brain-computer interface (BCI) company, has released the first public demonstration of an individual using an iPad controlled entirely by thought, leveraging Apple’s built-in accessibility ...
Synchron has raised a $200 million Series D financing round to accelerate the commercialization of its Stentrode brain-computer interface platform and advance the development of a next-generation ...
SAN FRANCISCO and NEW YORK CITY and MELBOURNE, Australia, Sept. 20 2019 /PRNewswire/ -- Synchron Inc. today announced the first successful clinical implantation of the Stentrode®, a minimally-invasive ...
NEW YORK, January 13, 2025--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of ...
The video features Mark, a participant in Synchron’s COMMAND clinical study and a person living with ALS, who uses the company’s implantable BCI to navigate the iPad home screen, open apps, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results